(E)-3-(4-bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-3-(4-bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one
• 英文别名: (E)-3-(4-bromophenyl)-1-(2-hydroxy-4-methoxy-phenyl)prop-2-en-1-one
• 化学式: C₁₆H₁₃BrO₃
• 分子量: 333.181
• InChiKey: BVTZXMDIICRCJC-RUDMXATFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-3-(4-bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 在 potassium hydroxide 、 双氧水 、 盐酸 作用下， 以 甲醇 、 水 为溶剂， 以70%的产率得到2-(4-bromophenyl)-3-hydroxy-7-methoxy-4H-chromen-4-one
  参考文献：
  名称：

  Rocaglaol derivatives as cardioprotectant agents

  摘要：

  本发明公开了新的罗钙素衍生物及其用途，用于预防或限制抗肿瘤剂的心脏毒性，特别是用于预防或限制由该剂诱导的心肌细胞凋亡。

  公开号：

  EP2189453A1
• 作为产物：
  描述：

  丹皮酚 、 对溴苯甲醛 在 potassium hydroxide 作用下， 以 乙醇 为溶剂， 以78 %的产率得到(E)-3-(4-bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one
  参考文献：
  名称：

  NaI介导的查耳酮电化学环化合成黄酮

  摘要：

  在这项工作中，我们展示了一种新型电化学氧化环化方法，用于从 2'-羟基查耳酮合成黄酮，使用廉价的低毒 NaI 作为介体/电解质，无需外部添加剂，在乙醇/水溶剂中。该反应的主要特点包括底物范围广泛、可扩展性、能够在室温下使用良性溶剂进行操作，并且不需要强氧化剂和外部添加剂。

  DOI：

  10.1002/ejoc.202300556

文献信息

• ROCAGLAOL DERIVATIVES AS CARDIOPROTECTANT AGENTS AND AS ANTINEOPLASTIC AGENTS
  申请人：Desaubry Laurent

  公开号：US20120101153A1

  公开（公告）日：2012-04-26

  The present invention discloses new rocaglaol derivatives and the use of rocaglaol derivatives to prevent or to limit the cardiotoxicity of an antineoplastic agent, in particular to prevent or to limit the apoptosis of cardiomyocytes induced by such agent.

  本发明揭示了新的洛卡格洛衍生物，并使用洛卡格洛衍生物来预防或限制抗肿瘤药物的心脏毒性，特别是预防或限制由该药物引起的心肌细胞凋亡。
• ——
  作者：Christelle Pouget、Catherine Fagnere、Jean‐Philippe Basly、Anne‐Elise Besson、Yves Champavier、Gerard Habrioux、Albert‐Jose Chulia

  DOI：10.1023/a:1014490817731

  日期：——

  Purpose. Aromatase inhibitors are known to prevent the conversion of androgens to estrogens and play a significant role in the treatment of estrogen dependent diseases such as breast cancer. Some flavonoids have been reported as potent aromatase inhibitors: therefore. in an effort to develop novel anti breast cancer agents. B ring substituted flavanones with a 7-methoxy group on A ring were synthesized and tested to assess their ability to inhibit aromatase activity and to determine the optimal B ring substitution pattern.Methods. A series of flavanones was prepared by cyclisation of 2'-hydroxychalcones previously obtained by Claisen-Schmidt condensation and the aromatase inhibitory activity or these compounds was investigated using human placental microsomes and radiolabeled [1.2,6,7-H-3]-androstenedione as substrate.Results. Almost all flavanones exhibited inhibitory effect on the aromatase activity but their potency was dependent on their B ring subtitution pattern. Hydroxylation at position 3' and/or 4' enhanced the anti-aromatase activity thus, 3'.4'-dihydroxy-7-methoxyflavanone was found to he twice more potent than aminoglutethimide. the first aromatase inhibitor clinically used.Conclusions. These results indicated that these flavanones could be considered as potential anti breast cancer agents through the inhibition of aromatase activity and allowed us to select some of these Compounds as skeleton for the development of flavonoid structurally-related aromatase inhibitors.
• [EN] ROCAGLAOL DERIVATIVES AS CARDIOPROTECTANT AGENTS AND AS ANTINEOPLASTIC AGENTS<br/>[FR] DÉRIVÉS DU ROCAGLAOL EN TANT QU'AGENTS CARDIOPROTECTEURS ET AGENTS ANTINÉOPLASIQUES
  申请人：UNIV STRASBOURG

  公开号：WO2010060891A1

  公开（公告）日：2010-06-03

  The present invention discloses new rocaglaol derivatives and the use of rocaglaol derivatives to prevent or to limit the cardiotoxicity of an antineoplastic agent, in particular to prevent or to limit the apoptosis of cardiomyocytes induced by such agent.
• Rocaglaol derivatives as cardioprotectant agents
  申请人：Université Louis Pasteur

  公开号：EP2189453A1

  公开（公告）日：2010-05-26

  The present invention discloses new rocaglaol derivatives and the use of rocaglaol derivatives to prevent or to limit the cardiotoxicity of an antineoplastic agent, in particular to prevent or to limit the apoptosis of cardiomyocytes induced by such agent.

  本发明公开了新的罗钙素衍生物及其用途，用于预防或限制抗肿瘤剂的心脏毒性，特别是用于预防或限制由该剂诱导的心肌细胞凋亡。
• Synthesis of Flavones through NaI‐Mediated Electrochemical Cyclization of Chalcones
  作者：Taweesak Gulchatchai、Thao Nguyen Thanh Huynh、Natthanan Vijara、Tanatorn Khotavivattana、Mongkol Sukwattanasinitt、Sumrit Wacharasindhu

  DOI：10.1002/ejoc.202300556

  日期：2023.9.21

  In this work, we demonstrated a novel electrochemical oxidative cyclization for synthesis of flavone from 2’-hydroxychalcone using an inexpensive using low toxic NaI as mediator/electrolyte without external additives in EtOH/water solvent. The key features of this reaction include its broad substrate scope, scalability, ability to operate with benign solvent at room temperature, and no requirement

  在这项工作中，我们展示了一种新型电化学氧化环化方法，用于从 2'-羟基查耳酮合成黄酮，使用廉价的低毒 NaI 作为介体/电解质，无需外部添加剂，在乙醇/水溶剂中。该反应的主要特点包括底物范围广泛、可扩展性、能够在室温下使用良性溶剂进行操作，并且不需要强氧化剂和外部添加剂。